Concepedia

Author

Jun Kong

Peking University People's HospitalORCID

Also Known As

, J Kong, J. Kong, JIEJUN KONG, Jia-wei Kong, Jiabing Kong, Jian Guo, Jing Ting Kong, Jun Chang Kong, Jun Kong

103

Publications

612

Citations

14

H-Index

25

Concepts

All Affiliations

Peking University People's HospitalPeking UniversityCenter for Life SciencesChinese Academy of Medical Sciences & Peking Union Medical CollegeNational Clinical Research Center for Digestive Diseases
JK

About

Jun Kong is an author at Peking University People's Hospital specializing in cell transplantation, transplantation, and marrow transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

183

2

Cellular Therapies

4

4

169

3

Health Sciences

3

3

77

4

Blood Transplantation

2

2

44

5

Engineering

1

1

47

Jun Kong

×

16

Publications

472

Citations

14

H-Index

YearCitations

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

Jun Liu, Jun Kong, Ying‐Jun Chang,

Clinical Microbiology and Infection

2015

92

Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation

Chen‐Hua Yan, Yu Wang, Xiao‐Dong Mo,

Clinical Infectious Diseases

2018

67

Coseismic Coulomb failure stress changes caused by the 2017 M7.0 Jiuzhaigou earthquake, and its relationship with the 2008 Wenchuan earthquake

Bin Shan, Yong Zheng, Chengli Liu,

Science China Earth Sciences

2017

47

Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy

Guan-Hua Hu, Xiang‐Yu Zhao, Ying‐xi Zuo,

Leukemia

2021

33

Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes

Xiao‐Dong Mo, Jun Kong, Ting Zhao,

Biology of Blood and Marrow Transplantation

2014

28

Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation

Chen‐Hua Yan, Yu Wang, Xiao‐Dong Mo,

Bone Marrow Transplantation

2020

27

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges

Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan,

Frontiers in Immunology

2024

24

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial

Hai‐Xia Fu, Xueyan Sun, Ren Lin,

BMC Medicine

2024

22

Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for children with very high‐risk philadelphia chromosome negative B‐cell acute lymphoblastic leukaemia in first complete remission

Yu‐juan Xue, Pan Suo, Xiao‐Jun Huang,

British Journal of Haematology

2019

21

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

Hao Jiang, Xiaohong Liu, Jun Kong,

Leukemia & lymphoma/Leukemia and lymphoma

2021

21

Page 1